Metraipolis › archive › dc_f8454b6daebc
Tocilizumab for critically ill patients with refractory anti-NMDAR encephalitis: a case report — Europe PMC PMID:42746239
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42746239
- DOI
- 10.3389/fimmu.2026.1809134
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:10:09.845Z
- SHA-256 of the archived text
e6d7feb64f297e79824c591b6583adf460033b232ea1acd80853f3504e550bdb- Stable URL of this page
https://metraipolis.com/documento/dc_f8454b6daebc
How to cite
Tocilizumab for critically ill patients with refractory anti-NMDAR encephalitis: a case report — Europe PMC PMID:42746239 — Europe PMC (en), https://europepmc.org/article/MED/42746239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8454b6daebc (Metraipolis archive dc_f8454b6daebc, sha256 e6d7feb64f297e79824c591b6583adf460033b232ea1acd80853f3504e550bdb)
BibTeX
@misc{dcf8454b6daebc,
title = {Tocilizumab for critically ill patients with refractory anti-NMDAR encephalitis: a case report — Europe PMC PMID:42746239},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42746239},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8454b6daebc; sha256 e6d7feb64f297e79824c591b6583adf460033b232ea1acd80853f3504e550bdb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746239. Agents can read the archived copy with the MCP tool read_document.